nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antithrombotic activity of suloctidil
|
Roba, J. |
|
1983 |
29 |
S1 |
p. 53-58 6 p. |
artikel |
2 |
Aspirin: Plasma concentration and effects
|
Thiessen, J.J. |
|
1983 |
29 |
S1 |
p. 105-111 7 p. |
artikel |
3 |
Clinical pharmacokinetics of dipyridamole
|
Bjornsson, Thorir D. |
|
1983 |
29 |
S1 |
p. 93-104 12 p. |
artikel |
4 |
Determinants of the pharmacokinetics of antithrombotic drugs
|
Marks, G.S. |
|
1983 |
29 |
S1 |
p. 17-27 11 p. |
artikel |
5 |
Dipyridamole disposition after chronic administration: Effect of aspirin
|
Rosenfeld, J. |
|
1983 |
29 |
S1 |
p. 137-143 7 p. |
artikel |
6 |
Effects of ticlopidine and dexamethasone on fibronectin and factor VIII-related antigen synthesis by cultured endothelial cells
|
Piovella, F. |
|
1983 |
29 |
S1 |
p. 69-73 5 p. |
artikel |
7 |
Final discussion and concluding comments
|
|
|
1983 |
29 |
S1 |
p. 185-190 6 p. |
artikel |
8 |
Foreword
|
Buchanan, M.R. |
|
1983 |
29 |
S1 |
p. v- 1 p. |
artikel |
9 |
Interaction of salicylate and other non-steroidal anti-inflammatory drugs with aspirin on platelet and vascular cyclo-oxygenase activity
|
Dejana, Elisabetta |
|
1983 |
29 |
S1 |
p. 153-159 7 p. |
artikel |
10 |
List of participants
|
|
|
1983 |
29 |
S1 |
p. vii-x nvt p. |
artikel |
11 |
Mechanism of action of dipyridamole
|
Harker, Laurence A. |
|
1983 |
29 |
S1 |
p. 39-46 8 p. |
artikel |
12 |
Mechanisms of action: Aspirin
|
Hoak, John C. |
|
1983 |
29 |
S1 |
p. 47-51 5 p. |
artikel |
13 |
Mechanisms of action of nafazatrom
|
Seuter, F. |
|
1983 |
29 |
S1 |
p. 75-80 6 p. |
artikel |
14 |
Mechanisms of action of sulphinpyrazone
|
Wallis, Robert B. |
|
1983 |
29 |
S1 |
p. 31-38 8 p. |
artikel |
15 |
Relevance to redesigning aspirin therapeutic regimens
|
Thiessen, J.J. |
|
1983 |
29 |
S1 |
p. 163-170 8 p. |
artikel |
16 |
Selective inhibition of thromboxane synthesis with dazoxiben in animals and man
|
Randall, M.J. |
|
1983 |
29 |
S1 |
p. 81-85 5 p. |
artikel |
17 |
Sulfinpyrazone: Relationship between dose, kinetics, plasma concentrations and biological effects
|
Buchanan, M.R. |
|
1983 |
29 |
S1 |
p. 89-92 4 p. |
artikel |
18 |
Suloctidil: Relationship between pharmacokinetics and antithrombotic effect
|
Roba, J. |
|
1983 |
29 |
S1 |
p. 113-118 6 p. |
artikel |
19 |
The effect of aspirin on the pharmacokinetics of sulfinpyrazone in man
|
Buchanan, M.R. |
|
1983 |
29 |
S1 |
p. 145-152 8 p. |
artikel |
20 |
The mechanisms of action of ticlopidine
|
Bruno, John J. |
|
1983 |
29 |
S1 |
p. 59-67 9 p. |
artikel |
21 |
The relationship between basic biomedical research and the design and analysis of clinical trials
|
Taylor, D.W. |
|
1983 |
29 |
S1 |
p. 171-183 13 p. |
artikel |
22 |
The relationship between dose, pharmacokinetics, plasma-concentrations and antithrombotic effects of nafazatrom
|
Philipp, E. |
|
1983 |
29 |
S1 |
p. 129-133 5 p. |
artikel |
23 |
Ticlopidine hydrochloride: Relationship between dose, kinetics, plasma concentration and effect on platelet function
|
Picard-Fraire, C. |
|
1983 |
29 |
S1 |
p. 119-128 10 p. |
artikel |
24 |
Variability in the human drug response
|
Sweeney, G.D. |
|
1983 |
29 |
S1 |
p. 3-15 13 p. |
artikel |